COCP - Cocrystal Pharma, Inc. Common Stock

Cocrystal Pharma, Inc. (COCP)

NCM · Common · CUSIP 19188J409

Last Price•••.••

Current Yield•.••%

Yield to Call•.••%

Yield to Worst•.••%

Free registration unlocks the quote, yield calculations, price chart and full fundamentals for COCP and every other security on QuantumOnline.

Overview Financials 🔒 Earnings 🔒 Dividends 🔒 Analysts 🔒 Ownership 🔒 ESG 🔒 Technicals 🔒

🔒

Price chart and 15 days of daily prices

Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type: Common Stock
CUSIP: 19188J409 (prev. 19188J300 )
Market Cap: Micro Cap

Links: Home Page Investor Relations News

Business: Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza viruses, and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs.

Company Contact

CEO: Sam Lee
CFO: James Martin
Headquarters: 19805 North Creek Parkway Bothell, WA 98011
Phone: 877-262-7123 · Toll-Free 877-262-7123
Fax: 404-601-1431
Investor Relations: Jody Cain, LHA Investor Relations · 310-691-7100 · jcain@lhai.com
General Email: info@cocrystalpharma.com
Email Form: Contact Form »
SEC EDGAR Filings: View filings »